This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fox, P. M.
Right arrow Articles by Climo, M. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fox, P. M.
Right arrow Articles by Climo, M. W.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, September 2006, p. 2951-2956, Vol. 50, No. 9
0066-4804/06/$08.00+0     doi:10.1128/AAC.00232-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Successful Therapy of Experimental Endocarditis Caused by Vancomycin-Resistant Staphylococcus aureus with a Combination of Vancomycin and ß-Lactam Antibiotics

Paige M. Fox,1 Russell J. Lampen,2 Katrina S. Stumpf,1 Gordon L. Archer,1,2 and Michael W. Climo1,2,3*

Departments of Microbiology and Immunology,1 Medicine, Virginia Commonwealth University School of Medicine,2 Hunter Holmes McGuire Veteran Affairs Medical Center, Richmond, Virginia3

Received 22 February 2006/ Returned for modification 18 April 2006/ Accepted 10 June 2006

VRS1 is the first isolated strain of vancomycin-resistant Staphylococcus aureus (VRSA) found to carry the vanA gene complex previously described in Enterococcus. Under vancomycin pressure, VRS1 makes aberrant cell walls consisting of stem tetrapeptide and depsipeptide that lack the terminal D-Ala-D-Ala residues targeted by vancomycin. Previous data have suggested that this aberrant cell wall is not cross-linked by PBP2a, the enzyme responsible for cell wall transpeptidation in the presence of ß-lactam antibiotics. We examined the efficacy of treating VRS1 with a combination of vancomycin and ß-lactam antibiotics in vitro and in vivo. We found that the MIC of oxacillin for VRS1 decreased from >256 µg/ml to <1 µg/ml in the presence of vancomycin. Using the rabbit model of endocarditis, we treated VRS1-infected rabbits with nafcillin alone, vancomycin alone, or a combination of nafcillin and vancomycin. Treatment with nafcillin in combination with vancomycin cleared bloodstream infections within 24 h and sterilized 12/13 spleens (92%), as well as 8/13 kidneys (62%), following 3 days of treatment. Mean aortic valve vegetation counts were reduced 3.48 log10 CFU/g with the combination therapy (compared to untreated controls) and were significantly lower than with either vancomycin or nafcillin given alone. VRS1 was extremely virulent in this model, as no untreated rabbits survived the 3-day trial. Treatment of clinical infections due to VRSA with the combination of vancomycin and ß-lactams may be an option, based on these results.

* Corresponding author. Mailing address: Hunter Holmes McGuire Veteran Affairs Medical Center, 1201 Broad Road Boulevard, Section 111-C, Richmond, VA 23249. Phone: (804) 675-5018. Fax: (804) 675-5437. E-mail: michael.climo{at}med.va.gov.

Antimicrobial Agents and Chemotherapy, September 2006, p. 2951-2956, Vol. 50, No. 9
0066-4804/06/$08.00+0     doi:10.1128/AAC.00232-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Perichon, B., Courvalin, P. (2009). VanA-Type Vancomycin-Resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 53: 4580-4587 [Abstract] [Full Text]  
  • Moubareck, C., Meziane-Cherif, D., Courvalin, P., Perichon, B. (2009). VanA-Type Staphylococcus aureus Strain VRSA-7 Is Partially Dependent on Vancomycin for Growth. Antimicrob. Agents Chemother. 53: 3657-3663 [Abstract] [Full Text]  
  • Mishra, N. N., Yang, S.-J., Sawa, A., Rubio, A., Nast, C. C., Yeaman, M. R., Bayer, A. S. (2009). Analysis of Cell Membrane Characteristics of In Vitro-Selected Daptomycin-Resistant Strains of Methicillin-Resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 53: 2312-2318 [Abstract] [Full Text]  
  • Noto, M. J., Fox, P. M., Archer, G. L. (2008). Spontaneous Deletion of the Methicillin Resistance Determinant, mecA, Partially Compensates for the Fitness Cost Associated with High-Level Vancomycin Resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 52: 1221-1229 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»